Team and Governance

The launch of the Marseille Immunology Biocluster (MIB)’s Scientific Advisory Board (SAB) marks a major milestone in the Biocluster’s journey. As President of this independent body, I am honored to join a panel of other globally respected experts spanning a wide spectrum of immunology research. Our mission to critically and independently assess the scientific merit of MIB’s research programs is not merely a responsibility, but a vital condition for credible, high-impact innovation. Scientific excellence thrives on constant challenge, fresh perspectives, and unwavering integrity, both from outside and from within. MIB has set itself a bold 10-year vision: to deliver a new generation of antibody-based therapies, including a blockbuster drug. The work ahead is substantial. But with clear purpose and uncompromising standards, such a goal is within reach. The importance of this endeavor cannot be overstated. Immunology sits at the crossroads of some of the most pressing health challenges of our time. It offers insights and, often, transformative solutions to major health needs such as cancer, infection, chronic inflammation, and autoimmune conditions. By investing in this field, and by holding its research to the highest standards, MIB is helping to drive progress that will be felt far beyond its borders. Our mission at the SAB is to accompany this effort with objectivity, critical insight, and a deep belief in the power of science. Together, with researchers, entrepreneurs, public stakeholders, and the broader community, we can turn today’s ideas into tomorrow’s therapies.

Pedro Romero President of the Scientific Advisory Board, Marseille Immunology Biocluster